Since the results shown here indicate that the loss of MMP14 catalytic activity may be the culprit in demise of new born, these findings may indeed shed some light on the failure of MMP inhibitors in clinical cancer trials (Overall & Kleifeld, 2006; Overall & Lopez-Otin, 2002). The gene discussed is MMP14; the disease is cancer.